How about delivery timel/method
NICE guideline review: Attention deficit hyperactivity disorder: diagnosis and management (NG87)
In this article, well jump into the specifics, providing you with the knowledge you need to make an informed decision about your fitness journey
serves or has served on scientific advisory boards and received honorarium or consulting fees from Amgen, Applied Therapeutics, Arrowhead, Biomea Fusion, Boehringer Ingelheim, Corcept, Eccogene, Eli Lilly, Hanmi, i2O Therapeutics, Novo Nordisk, Regeneron, Roche, Sanofi, Structure Therapeutics and Terns, and has received honoraria for lectures from Eli Lilly, Novo Nordisk and Sanofi
Weight of evidence: Overall evidence is Low-Moderate: multiple animal studies and a growing number of small clinical trials suggest benefits across gutbrain signaling, social and behavioral domains, gastrointestinal symptoms, and neurophysiological patterns, yet most human studies rely on caregiver-reported outcomes, lack biomarker integration, and seldom control for diet, comorbidities, or baseline microbiome composition